Medical Aspects of Chemical Warfare (2008) - The Black Vault

Medical Aspects of Chemical Warfare212. Lipp JA. Effect of benzodiazepine derivatives upon soma-induced seizure activity and convulsions in the monkey.Acta Int Pharmacodyn Ther. 1973;202:241–251.213. Rump S, Grudzinska E, Edelwejn Z. Effects of diazepam on abnormalities of bioelectrical activity of the rabbit’s braindue to fluostigmine. Act Nerv Super (Praha). 1972;14:176–177.214. Rump S, Grudzinska E, Edelwejn Z. Effects of diazepam on epileptiform patterns of bioelectrical activity of the rabbit’sbrain induced by fluostigmine. Neuropharmacology. 1973;12:813–817.215. Wills JH, McNamara BP, Fine EA. Ventricular fibrillation in delayed treatment of TEPP poisoning. Fed Proc.1950;9:136.216. Valero A, Golan D. Accidental organic phosphorus poisoning: the use of propranolol to counteract vagolytic cardiaceffects of atropine. Isr J Med Sci. 1967;3:582–584.217. Rotenberg JS, Newmark J. Nerve agent attacks on children: diagnosis and management. Pediatrics. 2003;112:648–658.218. Foroutan SA. Medical notes on chemical warfare, part I. Kowsar Med J. 1996;1:91–97.219. Foroutan SA. Medical notes on chemical warfare, part II. Kowsar Med J. 1997;1:159–177.220. Foroutan SA. Medical notes on chemical warfare, part III. Kowsar Med J. 1997;2:69–83.221. Foroutan SA. Medical notes on chemical warfare, part IV. Kowsar Med J. 1997; 2:141–151.222. Foroutan SA. Medical notes on chemical warfare, part V. Kowsar Med J. 1997;2:221–227.223. Foroutan SA. Medical notes on chemical warfare, part VI. Kowsar Med J. 1998;2:289–301.224. Foroutan SA. Medical notes on chemical warfare, part VII. Kowsar Med J. 1998;3:61–68.225. Foroutan SA. Medical notes on chemical warfare, part IX. Kowsar Med J. 1998;2:211–221.226. Foroutan SA. Medical notes on chemical warfare, part X. Kowsar Med J. 1999;3:278–290.227. Foroutan SA. Medical notes on chemical warfare, part XI. Kowsar Med J. 1999;4:64–67.228. Okumura T, Suzuki K, Fukuda A, et al. The Tokyo subway sarin attack: disaster management, part 2: hospital response.Acad Emerg Med. 1998; 5:618–624.229. Ohbu S, Yamashina A, Takasu N, et al. Sarin poisoning on Tokyo subway. Southern Med J. 1997;90:587–593.230. Okudera H, Morita H, Iwashita T, et al. Unexpected nerve gas exposure in the city of Matsumoto: report of rescueactivity in the first sarin gas terrorism. Am J Emerg Med. 1997;15:527–528.231. Kato T, Hamanaka T. Ocular signs and symptoms caused by exposure to sarin gas. Am J Ophthalmol. 1996;121:209–210.232. Morita H, Yanagisawa N, Nakajima T, et al. Sarin poisoning in Matsumoto, Japan. Lancet. 1995;346:290–293.233. Yokoyama K, Yamada A, Mimura N. Clinical profiles of patients with sarin poisoning after the Tokyo subway attack.Am J Med. 1996;100:586.234. Suzuki J, Kohno T, Tsukagosi M, Furuhata T, Yamazaki K. Eighteen cases exposed to sarin in Matsumoto, Japan. InternalMed. 1997;36:466–470.216